4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-21-005208
Options or other derivatives
- Director acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hatfield Jeffrey S. Director | 2021-02-04 | Grant or award · Director Stock Option (Right to Buy) | +25,000 | 25,000 | D | ||
Loading xslF345X03/doc4.xml…